Bmi z-score as a prognostic factor for height velocity in children treated with recombinant human growth hormone due to idiopathic growth hormone deficiency

HIGHLIGHTS

• What: The aim of this study was to analyze nutritional status along with height velocity in GHD during the first two years of rhGH therapy and to estimate the optimal BMI z-score range in which these achieve the best results. In children with GHD the primary goal of treatment is to normalize growth, which is based on an administration of recombinant human growth hormone (rhGH) in daily injections. For the purpose of the statistical analysis, participants were divided into sub-groups, according to their BMI z-score values recorded at the treatment beginning. The results of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.